References
- Ahmad, M., S.M. Srinivasula, L. Wang, R.V. Talanian, G. Litwack, T. Fernandes-Alnernri, and E.S. Alnernri, 1997. CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res. 57, 615-619
- Chang, H.Y. and X. Yang. 2000. Proteases for cell suicide: Functions and regulations of caspases. Microbiol. Mol. Biol. Rev. 64, 821-846 https://doi.org/10.1128/MMBR.64.4.821-846.2000
- Choi, J.W, D.Y Ryu., Y.K. Kim, E.G. Hong, M.S. Kwun, and J.S. Han. 2000. Extraction and purification ofbioactive materials from Agaricus blazei fruiting bodies. Korean J. Biotechnol. Bioeng. 15, 293-298
- Choi, Y.B., K.S. Kim, K.H. Lee, and H.S. Sohn. 1995. Development of soy oligosaccharides. Korea Soybean Digest. 12, 68-74
- Collette, Y., A. Gilles, P. Pontaroti, and D. Olive. 2003. A co-evolution perspective of the TNFSF and TNFRSF families in the immune system. Trends Immunol. 24, 387-394 https://doi.org/10.1016/S1471-4906(03)00166-2
- Ebina, T. and Y. Fugimiya. 1998. Antitumor effects of a peptideglucan preparation extractied from Agaricus blazei in a doublegrafted tumor system in mice. Biotherapy. 11, 259-265 https://doi.org/10.1023/A:1008054111445
- Ishii, K., T. Kita, J. Hirata, T. Tode, Y. Kikuchi, and I. Nagata. 1993. Antitumor effect of PSK and its combined effect with CDDP on ovarian serous adenocarcinoma-bearing nude mice. Nippon Sanko Fujinka Gakkai Zasshi. 45, 333-339
- Kawagishi, H., A. Nomura, T. Yumen, T. Mizuno, T. Hagiwara, and T. Nakamura. 1988. Isolation and properties of a lectin from the fruiting bodies of Agaricus blasei. Carbohydr. Res. 183, 150-154 https://doi.org/10.1016/0008-6215(88)80057-0
- Kidd, P.M. 2000. The use of mushroom glucans and proteoglycans in cancer treatment. Altern. Med. Rev. 5, 4-27
- Kim, J.Y., W.K. Kim, H.Y. Kim, M.H. Kim, and S.H. Kim. 2000. Effects of soyoligosaccharides and varing dietary fats on intestinal microflora, lipid profiles and immune responses in rats. Korean J. Nutrition. 33, 597-612
-
Kim, K.H., Y.O. Kim, B.S. Ko, H.J. Youn, and D.S. Lee. 2004. Overexpression of the gene(bglBCI) from Bacillus circulans encoding an endo-
$\beta$ -(1$\rightarrow$ 3), (1$\rightarrow$ 4)-glucanase useful for the preparation of oligosaccharides from barley$\beta$ -glucan. Biotechnol. Lett. 26, 1749-1755 https://doi.org/10.1007/s10529-004-4581-1 -
Kim, Y.W., K.H. Kim, H.J. Choi, and D.S. Lee. 2005. Anti-diabetic activity of
$\beta$ -glucans and their enzymatically hydrolyzed oli-gosaccharides frorn Agaricus blazei. Biotechnol. Leu. 27, 483-487 https://doi.org/10.1007/s10529-005-2225-8 - Lee, M.H., H.J. Lee, and I.S. Cho. 1998. Chemical composition of Agaricus blazei Murill fruiting bodies cultivated in a Korea local farm. J. Fd Hyg. Safety. 13, 94-98
- Liu, Z.J., X. Lu, and S. Zhong. 2005. ASPP-Apoptotic specific regulator of p53. Biochim. Biophys. Acta. 1756, 77-80
- Moon, B.K. 2002. Anesthesiology and apoptosis. Korean J. Anesthesiol. 42, 563-574 https://doi.org/10.4097/kjae.2002.42.5.563
- Zha, J., H. Harada, K. Osipov, J. Jockel, G. Waksman, and S.J. Korsmeyer. 1997. BH3 domain of BAD is required for heterodimerization with BCL-XL and pro-apoptotic activity. J. Biol. Chem. 272, 24101-24104 https://doi.org/10.1074/jbc.272.39.24101
- Mishra, S., L.C, Murphy, B.L.G. Nyomba, and L.J. Murphy. 2005. Prohibitin: a potential target for new therapeutics. Trends Mol. Med. 11, 192-197 https://doi.org/10.1016/j.molmed.2005.02.004
- Peris, K., G. Stanta, M.C. Fargnoli, S. Bonin, A. Felli, A. Amantea, and S. Chimenti. 1999. Reduced expression of CDKN2a/p16INK4a in mycosis fungoldes. Arch. Dermatol. Res. 291, 207-211 https://doi.org/10.1007/s004030050395
- Seo, B.I. 2003. A study on Agaricus blazei. J. Appl. Oriental Medicine. 3, 83-89
- Sherr, C.J. 1995. Mammalian G1 cyelins and cell cyele progression. Proc. Assoc. Am. Physicians. 107, 181-186
- Suzuki, M., S. Higuchi, Y. Taki, S. Taki, K. Miwa, and J. Hamuro. 1990. Induction of endogenous Iymphokine-activated killer activity by combined administration of lentinan and interleukin 2. Int. J. Immunophannacol. 12, 613-623 https://doi.org/10.1016/0192-0561(90)90098-8
- Taper, H.S. and M.B. Roberfroid. 2002. Inulin/oligofructose and anticancer therapy. British J. Nutrition. 87, S283-S286 https://doi.org/10.1079/BJN/2002549
- Tsukamoto, K., N. Ohta, Y. Shirai, and M. Emi. 1998. A highly polymorphic CA repeat marker at the human interleukin 6 receptor (IL6R) locus. J. Hum. Genet. 43, 289-290
- Vermes, I., C. Haanen, H. Steffens-Nakken, and C. Reuteling-sperger. 1995. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Meth. 184, 39-51 https://doi.org/10.1016/0022-1759(95)00072-I
- Volpert, O., W. Luo, T.J. Liu, V.T. Estrera, C. Logothetis, and S.H. Lin. 2002. Inhibition of prostate tumor angiogenesis by the tumor suppressor CEACAM1. J. Biol. Chem. 277, 35696-35702 https://doi.org/10.1074/jbc.M205319200
- Wehrli, P., I. Viard, R. Bullani, J. Tschopp, and L.E. French. 2000. Death receptors in cutaneous biology and disease. J. Invest. Dermatol. 115, 141-148 https://doi.org/10.1046/j.1523-1747.2000.00037.x
- Yamanaka, R., J. Honma, N. Tsuchiya, N. Yajima, T. Kobayashi, and R. Tanaka. 2005. Tumor lysate and IL-18 loaded dendritic cells elicits Th1 response, tumor-specific CD8+ cytotoxic T cells in patients with malignant glioma. J. Neuro-Oncol. 72, 107-113 https://doi.org/10.1007/s11060-004-3550-9
- Zhou, Y., S. Wang, A. Gobi, and K. Oberg. 2000. The interferon-a regulation of interferon regulatory factor 1(IRF-l) and IRF-2 has therapeutic implications in carcinoid tumors. Ann. Oncol. 11, 707-714 https://doi.org/10.1023/A:1008314804492